Transcatheter Aortic Valve Replacement: Comparing Transfemoral, Transcarotid and Transcaval Access

Conclusions Patients unsuitable for TF TAVR treated with TC or TCav access had 30-day/in-hospital and 1-year survival similar to a contemporary cohort undergoing TF access. Avoiding surgical entry to the chest may offer procedural and intermediate term outcomes equivalent to TF TAVR.
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research